Gut Bacteria Drive Nearly a Third of Obesity’s Colorectal Cancer Risk, Study Finds

Obesity is an established risk factor for colorectal cancer, but the biological chain connecting extra body weight to a tumour in the colon has never been fully traced. A large Mendelian randomisation study, published in the International Journal of Obesity, now points to an unexpected intermediary: the gut microbiome, and specifically a bacterial phylum called Actinobacteria. The finding is preliminary, but if it holds up, it suggests that changing what lives in your gut could one day reduce colorectal cancer risk in people with obesity.

Actinobacteria Linked to Colorectal Cancer Risk in 1.18 Million People

The study drew on genome-wide association study (GWAS) data covering 384,738 cancer cases and 799,908 controls of European ancestry, making it one of the largest analyses of obesity, the microbiome, and cancer risk conducted to date. Researchers used two-sample Mendelian randomisation, a method that uses genetic variants as stand-ins for an exposure (here, BMI or gut bacteria abundance) to infer causal direction while reducing the confounding that plagues ordinary observational studies.

Genetically predicted BMI was robustly associated with increased risk of colorectal cancer (odds ratio per standard deviation: 1.12), renal cell carcinoma (1.48), endometrial cancer (1.70), lung cancer (1.20), and oesophageal cancer (1.25). Waist-to-hip ratio adjusted for BMI, a measure of central adiposity, was independently associated with colorectal and oesophageal cancer risk. No significant association appeared for prostate cancer.

On the microbial side, higher genetically predicted abundance of phylum Actinobacteria, order Bifidobacteriales, and family Bifidobacteriaceae were each linked to elevated colorectal cancer risk. These associations were replicated in the FinnGen cohort, a biobank of roughly 500,000 Finns, adding confidence to the finding. Family Oxalobacteraceae and the genus Ruminococcus torques group were associated with lower colorectal cancer risk.

How Obesity May Fuel Colorectal Cancer Through Gut Microbes

The mediation analysis is the study's most striking element. Phylum Actinobacteria accounted for 29% (confidence interval: 8 to 50%) of the total effect of BMI on colorectal cancer risk; class Actinobacteria accounted for 21% (CI: 4 to 37%). In other words, when BMI goes up, Actinobacteria abundance appears to follow, and that shift in the microbial landscape may partly explain why heavier people face higher colorectal cancer rates.

The mechanism is not yet pinned down. Instrumental variables for Actinobacteria were associated with lipid metabolites in follow-up analyses, hinting at a metabolic channel. One intriguing thread: the genetic variants used as proxies for Actinobacteria overlap with lactase nonpersistence variants, which reduce dairy consumption. Lower dairy intake has been associated in other research with modestly higher colorectal cancer risk, though the authors caution this pathway needs direct investigation before any conclusions can be drawn.

Research on climate risk accelerates financial distress in companies offers a useful structural analogy: just as intermediate mechanisms can amplify an upstream exposure into downstream harm, gut bacteria appear to act as an amplifier that translates excess adiposity into cancer-promoting biology.

Why Mendelian Randomisation Strengthens the Causal Inference

Correlation between gut bacteria and disease is easy to find; causation is hard to establish because disease itself reshapes the microbiome. This study's use of Mendelian randomisation addresses that reverse-causation problem by anchoring exposures to genetic variants fixed at birth. The microbiome GWAS came from the MiBioGen consortium, which profiled 211 microbial taxa in 18,340 individuals, one of the largest such datasets available.

Instrument strength was validated with F-statistics above 55.8 for BMI and 54.2 for waist-to-hip ratio, well above the conventional threshold of 10 that signals weak instrument bias. The team also recalculated colorectal and oesophageal cancer GWAS statistics after excluding UK Biobank participants to prevent sample overlap from inflating associations.

Some discrepancies with earlier studies, particularly around the genera Tyzzerella3 and Ruminococcus torques group, were attributed to methodological differences or the possibility that CRC itself alters microbiome composition in ways that observational studies can't separate from pre-existing microbial patterns.

Key Limitations That Temper the Finding

Actinobacteria is a vast phylum. Bifidobacterium, the probiotic genus found in yoghurt, belongs here, as do disease-associated genera with very different biology. Saying Actinobacteria raises colorectal cancer risk is therefore a blunt statement: it may reflect the behaviour of a specific subset of taxa hiding inside a broad category. Better-stratified GWAS data, drilling down to genus and species level within Actinobacteria, are needed before any specific microbe can be named as a target.

The MiBioGen consortium also includes participants across a wide age range, from children to older adults, and roughly a quarter were of non-European ancestry. Because the analyses were conducted primarily in European-ancestry cancer cohorts, the findings may not translate cleanly to other populations. Finally, the mediation confidence intervals are wide, meaning the true proportion of obesity's colorectal cancer effect that travels through Actinobacteria could be anywhere from 8% to 50%.

These are genuine constraints, and they matter. Challenges in drawing causal conclusions from complex biological datasets are well recognised, and this study is no exception; the authors are appropriately careful to frame their mediation estimates as preliminary.

Diet and Microbiome Modulation as Possible Prevention Tools

If Actinobacteria does mediate a meaningful slice of obesity-driven colorectal cancer risk, the implication is that the gut microbiome becomes a modifiable target sitting between BMI and cancer. Diet, prebiotics, and probiotic supplementation can all shift Actinobacteria abundance, at least in the short term. The authors raise the possibility that dietary interventions could reduce colorectal cancer risk in people with obesity, though they stop well short of recommending any specific change.

The practical path forward involves finer-grained microbial GWAS to identify which Actinobacteria taxa are actually driving the signal, followed by observational studies to test whether dairy intake or other dietary factors genuinely mediate the obesity-colorectal cancer-microbiome triangle. Research on how firms proactively adopt adaptation strategies when facing forecasted exposures parallels the logic here: knowing where a risk concentrates is the prerequisite for targeted action.

For now, the message for clinicians is one of added biological plausibility rather than a change in practice. Obesity remains a well-supported colorectal cancer risk factor. What this study adds is a specific microbial candidate that may partly explain why, and a hypothesis about how that risk might eventually be intercepted before it becomes a tumour.

Evidence rating

EMERGING — 94/100

Caveats:

• Funding source was not disclosed in the article, so independent verification of the research cannot be confirmed.
• The Actinobacteria phylum is highly diverse; which specific species within it drive CRC risk remains unknown and requires further investigation.
• All participants were of European ancestry, limiting generalisability to other populations.
• Mendelian randomisation establishes a causal inference framework, but the precise biological mechanism — including whether dairy intake or lipid metabolism is the key intermediary — has not yet been directly tested in humans.
• The MiBioGen GWAS used to instrument the microbiome was not age-stratified and included both adults and children, introducing potential noise in microbial instruments.

Two-sample Mendelian randomisation study drawing on GWAS data from 384,738 cancer cases and 799,908 controls, with replication in the FinnGen cohort. The design supports causal inference rather than mere association, though the specific biological pathway through Actinobacteria remains incompletely characterised. Independent replication at the taxon level is partial, and further stratified GWAS are needed to identify actionable microbial targets within the diverse Actinobacteria phylum.

References

1. Thomas Yates, Molly Went, Charlie Mills, Philip Law, Richard Houlston (2026). Relationship between the microbiome and obesity-associated cancer risk using Mendelian randomisation. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02032-3
2. WeiWei Li, Junwen Yang, Zihao Ning (2024). Climate risk exposure and corporate financial distress. Applied Economics Letters. https://doi.org/10.1080/13504851.2024.2383258
3. Shauhrat S. Chopra, Sachini Supunsala Senadheera, Pavani Dulanja Dissanayake, et al. (2024). Navigating the Challenges of Environmental, Social, and Governance (ESG) Reporting: The Path to Broader Sustainable Development. Sustainability. https://doi.org/10.3390/su16020606
4. Xia Li (2024). Physical climate change exposure and firms' adaptation strategy. Strategic Management Journal. https://doi.org/10.1002/smj.3674